Back to Authors

Goldschmidt, Andrea B.

https://orcid.org/0000-0003-1620-8300

Mayo Clinic

University of Pittsburgh

Citations 3

Screening and Monitoring for Eating Disorders in Youth Presenting for Obesity Treatment
Tanner, Anna B. , Williams, Alison , Williams, Lesley, Goldschmidt, Andrea B.

Pediatrics Open Science | January 22, 2025 | Volume: 1 | Issue: 1 | Pages: 1-4

10.1542/pedsos.2024-000333 Get It

Psychotropic medication use in treatment‐seeking youth with eating disorders
Gorrell, Sasha , Lebow, Jocelyn , Kinasz, Kathryn , Goldschmidt, Andrea B. , Accurso, Erin C. , Accurso, Erin C , Goldschmidt, Andrea B , Lebow, Jocelyn , Mitchell, James E., Grange, Daniel Le

European Eating Disorders Review | September 27, 2020 | Volume: 28 | Issue: 6 | Pages: 739-749

10.1002/erv.2788 Get It

AbstractObjectivePsychotropic medication use in youth with eating disorders (EDs) is poorly understood despite high co‐occurrence of psychiatric disorders. This study examined characteristics associated with medication use in treatment‐seeking youth with EDs.MethodYouth up to age 18 reported on medication use when presenting to an academic medical center outpatient ED service in the United States. Data presented were collected between 1998–2015.ResultsThe sample (N = 604) was predominantly female (90.6%) with a mean age of 15.3 years (SD = 2.3). Approximately one‐third (30%, n = 173) were taking psychotropic medications (40%, n = 70, were taking multiple medications). Antidepressant use was most common (26%, n = 152), followed by atypical antipsychotics (8%, n = 43). Adjusting for co‐occurring psychiatric disorders, non‐Hispanic Whites who had received prior treatment (psychotherapy, hospitalization) were significantly more likely to be using medication. Longer illness duration and prior treatment were associated with greater antidepressant use. For atypical antipsychotics, prior hospitalization was associated with greater use.ConclusionsFindings confirm moderate psychotropic medication use among young patients with EDs despite a lack of clarity regarding optimally effective pharmacologic interventions in this population. Pharmacological trials examining the efficacy of medications for young patients with EDs are warranted to inform future prescribing practice.
Weight gain trajectories during outpatient family‐based treatment for adolescents with anorexia nervosa
Lebow, Jocelyn , Sim, Leslie , Goldschmidt, Andrea B. , Grange, Daniel Le , Accurso, Erin C. , Goldschmidt, Andrea B , Le Grange, Daniel , Accurso, Erin C , Lebow, Jocelyn , Crosby, Ross D.

International Journal of Eating Disorders | December 22, 2018 | Volume: 52 | Issue: 1 | Pages: 88-94

10.1002/eat.23000 Get It

AbstractObjectiveGiven that weight gain patterns in adolescents receiving outpatient Family‐Based Treatment (FBT) have not been characterized, the purpose of this study was to examine trajectories of weight gain in a group of adolescent patients with a restrictive eating disorder [e.g., anorexia nervosa (AN) and atypical AN] receiving FBT. This study also examined the association of patient characteristics with weight gain trajectories, including age, diagnosis, weight suppression, presenting BMI‐for‐age percentile, and eating pathology.MethodLatent growth mixture modeling was used to identify distinct weight trajectories, as defined by change in BMI‐for‐age percentile, for 153 adolescents with AN or atypical AN, receiving FBT.ResultsThere were five distinct weight gain trajectory profiles for adolescents receiving FBT for a restrictive eating disorder. Younger age and greater weight suppression were associated with more rapid weight gain trajectories. A pattern of slow and consistent weight gain was associated with older age and less eating pathology.DiscussionThere was considerable variability in weight gain trajectories in youth receiving outpatient FBT for a restrictive eating disorder. This suggests that patients' presenting information can be used to inform expectations regarding weight gain trajectories.